Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank31
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P31
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -63.29% |
| Q2 2025 | 43.17% |
| Q1 2025 | 52.07% |
| Q4 2024 | -390.00% |
| Q3 2024 | 202.04% |
| Q2 2024 | 88.06% |
| Q1 2024 | -429.68% |
| Q4 2023 | -78.16% |
| Q3 2023 | 11.22% |
| Q2 2023 | 52.88% |
| Q1 2023 | 88.60% |
| Q4 2022 | 78.32% |
| Q3 2022 | -34.93% |
| Q2 2022 | -325.31% |
| Q1 2022 | 86.43% |
| Q4 2021 | 36.41% |
| Q3 2021 | -1113.94% |
| Q2 2021 | 2.85% |
| Q1 2021 | -541.72% |
| Q4 2020 | -86.36% |
| Q3 2020 | 442.90% |
| Q2 2020 | -12595.81% |
| Q1 2020 | 50.09% |
| Q4 2019 | -236.99% |
| Q3 2019 | -42.64% |
| Q2 2019 | 7.69% |
| Q1 2019 | 8.33% |
| Q4 2018 | 24.87% |
| Q3 2018 | 38.67% |
| Q2 2018 | 2.06% |
| Q1 2018 | 1643.18% |
| Q4 2017 | -450.00% |
| Q3 2017 | 0.00% |